Buspirone Hydrochloride

็›้…ธไธ่žบ็Žฏ้…ฎ

Report date: 2026/05/02 20:00:18
NME

Base Information

Drug NameBuspirone Hydrochloride
Drug Alias Nameไธ่žบ็Žฏ้…ฎ็›้…ธ็›buspironaBuspironumไธ่žบๆ—‹้…ฎ็›้…ธ็›็›้…ธไธ่žบๆ—‹้…ฎ +[12]ย 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor partial agonistsDopamine D2 receptor antagonists
TargetsSerotonin 1a (5-HT1a) receptorDopamine D2 receptor
Therapy Area/IndicationsSolid tumoursSchizophreniaAutistic Disorder +[28]ย 
Global Approved IndicationsAnxiety DisordersAnxiety
Approved Indications in ChinaAnxiety Disorders
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryUnited StatesRussian FederationUnited Kingdom +[5]ย 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active IndicationsAnxiety DisordersSubstance Withdrawal SyndromeOpium Dependence +[10]ย 
Inactive IndicationsSolid tumoursSchizophreniaAutistic Disorder +[18]ย 

Other Information

ATC CodeN05BE01